Birth outcomes in women with and without RSV infection during pregnancy.

<p>Birth outcomes in women with and without RSV infection during pregnancy.</p

Flow diagram of study participants.

<p>Study participants were monitored with weekly active home-based surveillance for febrile respiratory illness over three years.</p

Comparison of sociodemographic and clinical characteristics of women with and without RSV infection.

<p>Comparison of sociodemographic and clinical characteristics of women with and without RSV infection.</p

Heatmap of symptoms in women with respiratory syncytial virus infection.

<p>Heatmap with symptoms in women with respiratory syncytial virus infection during pregnancy (top) and after delivery (bottom) over the duration of the illness episodes. The color intensity of the box represents the number of participants with symptoms, with each box representing one day.</p

Illness episode characteristics of mothers with RSV infection during pregnancy and the postpartum period.

<p>Illness episode characteristics of mothers with RSV infection during pregnancy and the postpartum period.</p

Annualized rates of HIV infection among male and female VCT clients in Moshi, Tanzania, 2003–2007.

*<p>Rates of HIV infection per 100 person years at risk</p

Correlates of HIV infection by gender among 6,104 clients presenting for VCT in Moshi, Tanzania, 2003–2007.

<p>Odds ratios and [95% confidence intervals] from logistic regression models predicting seropositivity. ^*, ^**, and ^*** denote statistical significance at the 0.05, 0.01, and 0.001 levels, respectively. Ref. denotes reference category. Observations with missing covariates were dropped from the analysis. TSH, Tanzania shilling.</p

HIV seropositivity among women and men presenting for VCT, by number of lifetime partners and age of tester in Moshi, Tanzania, 2003–2007.

<p>Among women, subjects between 30 and 39 years old had the highest risk of seropositivity in each category of lifetime sexual partners (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003075#pone-0003075-g002" target="_blank">Figure 2</a>, Panel A), while subjects 40 years or older had the greatest rise in risk of seropositivity with increasing numbers of sexual partners. The associations were similar but not as strong among men (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003075#pone-0003075-g002" target="_blank">Figure 2</a>, Panel B). Non-parametric trend tests of associations between the number of partners and seropositivity were significant among men in the youngest and two oldest age groups only (p = 0.016; p = 0.035; and p = 0.001, respectively) and among women showed significant effects in all age groups (p<0.0001 to p = 0.006).</p

Absolute risk of HIV seropositivity among women and men presenting for VCT, by number of lifetime sexual partners in Moshi, Tanzania, 2003–2007, N = 6,531.

<p>Absolute risk of HIV seropositivity among women and men presenting for VCT, by number of lifetime sexual partners in Moshi, Tanzania, 2003–2007, N = 6,531.</p